Medical specialists from France tagged as investigators in clinical trials studying Eosinophilic Granulomatosis With Polyangiitis
Total 11 results
-
Antoine NeelSeen in:
- Nantes Cedex 1, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions: -
Arnaud BourdinSeen in:
- Montpellier Cedex 5, GSK Investigational Site
- Montpellier cedex 5, GSK Investigational Site
Trials:- NCT04718389 (Principal Investigator)
- NCT05263934 (Principal Investigator)
Conditions: -
Benjamin TerrierSeen in:
- Paris, GSK Investigational Site
- Paris, Hôpitaux Cochin - Port Royal
Trials:- NCT05263934 (Principal Investigator)
- NCT04885452 (Principal Investigator)
-
Bruno VillemagneSeen in:
- La Roche Sur Yon, La Roche-sur-Yon, CHD Vendee
- La Roche sur Yon Cedex 9, GSK Investigational Site
- La Roche sur Yon, CHD Vendee
- Vendee, La Roche-sur-Yon, CHD Vendee
Trials:- NCT05263934 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05023980 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Carole LacoutSeen in:
- Angers Cedex 09, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions: -
Claire de MoreuilSeen in:
- Brest Cedex, GSK Investigational Site
- Brest, CHU La Cavale Blanche
Trials:- NCT05263934 (Principal Investigator)
- NCT01034969 (Principal Investigator)
-
Guillaume LefevreSeen in:
- Lille Cedex, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions: -
Jean-Emmanuel KahnSeen in:
- Suresnes, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions: -
Jean-François ViallardSeen in:
- Pessac, CHU Bordeaux - Hopital Haut-Leveque
- Pessac, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
- NCT05879757 (Principal Investigator)
-
Loic GuillevinSeen in:
- Paris, Cochin Hospital, Université Paris-descartes
Trials:- NCT01066208 (Principal Investigator)
-
stanislas faguerSeen in:
- Toulouse Cedex 9, CHU de Toulouse - Hôpital Rangueil
- Toulouse, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
- NCT02664753 (Principal Investigator)
Clinical Trials on Eosinophilic Granulomatosis With Polyangiitis
-
Assistance Publique - Hôpitaux de ParisFrench Vasculitis Study GroupCompletedEosinophilic Granulomatosis With Polyangiitis (EGPA)France
-
Medical University InnsbruckRecruitingEosinophilic Asthma | Eosinophilic Pneumonia | EGPA - Eosinophilic Granulomatosis With Polyangiitis | Samter Triad | HES - Hypereosinophilic SyndromeAustria
-
Imperial College LondonAstraZenecaEnrolling by invitationEGPA - Eosinophilic Granulomatosis With PolyangiitisUnited Kingdom
-
University of PennsylvaniaUniversity of South Florida; University of OxfordCompletedVasculitis | Churg-Strauss Syndrome (CSS) | Microscopic Polyangiitis (MPA) | Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) (EGPA) | Granulomatosis With Polyangiitis (Wegener's) (GPA) | Wegener Granulomatosis (WG) | ANCA-Associated Vasculitis (AAV)United States
-
University Medical Center GroningenGlaxoSmithKlineRecruitingEGPA - Eosinophilic Granulomatosis With PolyangiitisNetherlands
-
Portsmouth Hospitals NHS TrustCompletedChurg-Strauss SyndromeUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisFrench Vasculitis Study GroupActive, not recruitingEosinophilic Granulomatosis With PolyangiitisFrance
-
National Jewish HealthTeva Pharmaceuticals USAUnknown
-
GlaxoSmithKlineNational Institute of Allergy and Infectious Diseases (NIAID)CompletedA Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With PolyangiitisChurg-Strauss SyndromeUnited States, France, Japan, Spain, Italy, Germany, Canada, Belgium, United Kingdom
-
GlaxoSmithKlineActive, not recruiting